Two deal releases from the November 5 wire, both worth reading for what the headline number leaves out. One is a medical device round with a strategic buyer in the lead. The other is an Israeli software roll-up taking another step.
Laza Medical, up to 160 million dollars from GE HealthCare
Laza Medical is building a robotic imaging system for the cardiac catheterization lab, combining robotic guidance with AI to help teams during complex interventional procedures. GE HealthCare led the Series B. AMED, PA MedTech and Unorthodox Ventures, earlier backers, came back in. Laza is part of Shifamed, the medtech incubator run by Amr Salahieh, who is Laza’s founder and chairman.
Read the words around the number. “Up to” $160 million and “structured financing” usually mean the money arrives in tranches tied to milestones, so the full amount depends on Laza hitting them. And the product has no regulatory clearance anywhere yet. It’s still in development.
The lead investor is the real story. GE HealthCare sells cath lab imaging systems, and leading a round for a company that wants to change how those labs work looks like an option on the technology, and perhaps on the company. Strategic investors in medtech usually negotiate rights of first look or first refusal. The release doesn’t say whether GE has one. Laza’s last round, a $36 million Series A, also had GE HealthCare in it.
Priority Software buys Fireberry
Priority Software, the Israeli ERP vendor, bought Fireberry, the Tel Aviv CRM company formerly called Powerlink. The release calls it part of an “AI-first vision.” The numbers are plainer. The deal values Fireberry at more than NIS 100 million, about $31 million. Priority buys more than half the shares now and gets an option on the rest from founder Amir Segev. Fireberry has about 30 employees and thousands of customers, mostly in Israel.
It’s Priority’s fifth acquisition since Blackstone took control in 2024, at a valuation of about $800 million, and its largest under Blackstone. Priority sells to 75,000 customers in 70 countries. Adding a CRM it can bundle with its ERP is the standard private-equity playbook: buy small products, cross-sell them into the installed base, and grow revenue per customer ahead of an exit.
What to take from them
Both releases lead with technology and are really about structure. Milestone tranches and a strategic lead in one, majority control with an option in the other. When a release says “up to” or “expands its portfolio,” look for the terms underneath. For Laza, the next number to watch is its first regulatory submission date, because that decides how much of the $160 million ever arrives.